[go: up one dir, main page]

FI974601L - Peptid som inhiberar en förhöjning av friglyceridnivån i blodet och inhibitor för förhöjning av triglyceridnivån i blodet, vilken innehåller nämnda peptid som aktiv ingrediens - Google Patents

Peptid som inhiberar en förhöjning av friglyceridnivån i blodet och inhibitor för förhöjning av triglyceridnivån i blodet, vilken innehåller nämnda peptid som aktiv ingrediens Download PDF

Info

Publication number
FI974601L
FI974601L FI974601A FI974601A FI974601L FI 974601 L FI974601 L FI 974601L FI 974601 A FI974601 A FI 974601A FI 974601 A FI974601 A FI 974601A FI 974601 L FI974601 L FI 974601L
Authority
FI
Finland
Prior art keywords
peptide
elevation
blood triglyceride
active ingredient
inhibitor containing
Prior art date
Application number
FI974601A
Other languages
English (en)
Finnish (fi)
Other versions
FI974601A0 (sv
FI116660B (sv
Inventor
Kyoichi Kagawa
Chizuko Fukuhama
Hisako Matsutaka
Toyoo Nakamura
Masahiro Numata
Shigeaki Watanabe
Kazuhisa Honda
Original Assignee
Hankyu Kyoei Bussan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14126034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI974601(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hankyu Kyoei Bussan Co Ltd filed Critical Hankyu Kyoei Bussan Co Ltd
Publication of FI974601A0 publication Critical patent/FI974601A0/sv
Publication of FI974601L publication Critical patent/FI974601L/sv
Application granted granted Critical
Publication of FI116660B publication Critical patent/FI116660B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795Porphyrin- or corrin-ring-containing peptides
    • C07K14/805Haemoglobins; Myoglobins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI974601A 1995-06-23 1997-12-22 Peptid som inhiberar en förhöjning av friglyceridnivån i blodet och inhibitor för förhöjning av triglyceridnivån i blodet, vilken innehåller nämnda peptid som aktiv ingrediens FI116660B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9501264 1995-06-23
PCT/JP1995/001264 WO1997000890A1 (fr) 1995-06-23 1995-06-23 Peptide qui inhibe l'elevation du niveau de triglyceride dans le sang, et inhibiteur d'elevation de ce niveau contenant ledit peptide comme principe actif

Publications (3)

Publication Number Publication Date
FI974601A0 FI974601A0 (sv) 1997-12-22
FI974601L true FI974601L (sv) 1997-12-22
FI116660B FI116660B (sv) 2006-01-31

Family

ID=14126034

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974601A FI116660B (sv) 1995-06-23 1997-12-22 Peptid som inhiberar en förhöjning av friglyceridnivån i blodet och inhibitor för förhöjning av triglyceridnivån i blodet, vilken innehåller nämnda peptid som aktiv ingrediens

Country Status (8)

Country Link
EP (1) EP0838474B1 (sv)
KR (1) KR100262468B1 (sv)
AT (1) ATE292142T1 (sv)
AU (1) AU708938B2 (sv)
DK (1) DK0838474T3 (sv)
ES (1) ES2238682T3 (sv)
FI (1) FI116660B (sv)
WO (1) WO1997000890A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10105041A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
GB0211849D0 (en) * 2002-05-23 2002-07-03 Mok Kenneth H Improvments to retro-inverso isomers
JP4395658B2 (ja) * 2005-11-17 2010-01-13 エムジーファーマ株式会社 コレステロール再上昇抑制用組成物およびその用法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1335567C (en) * 1988-02-02 1995-05-16 Kyoichi Kagawa Lipid metabolism promoting agent
JPH0331298A (ja) * 1989-06-28 1991-02-12 Ajinomoto Co Inc プロリルエンドペプチターゼ阻害ペプチド
JPH03167199A (ja) * 1989-11-24 1991-07-19 Yamanouchi Pharmaceut Co Ltd 新規ヘプタペプチド
JP3312944B2 (ja) * 1993-03-24 2002-08-12 伊藤ハム株式会社 脂肪細胞分化抑制ペプチド及び当該ペプチドを有効成分とする脂肪細胞分化抑制剤
JP2800877B2 (ja) * 1993-12-28 1998-09-21 伊藤ハム株式会社 血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤

Also Published As

Publication number Publication date
ES2238682T3 (es) 2005-09-01
FI974601A0 (sv) 1997-12-22
EP0838474A4 (en) 2001-04-18
EP0838474B1 (en) 2005-03-30
AU708938B2 (en) 1999-08-19
ATE292142T1 (de) 2005-04-15
FI116660B (sv) 2006-01-31
KR100262468B1 (ko) 2000-08-01
AU2753295A (en) 1997-01-22
EP0838474A1 (en) 1998-04-29
WO1997000890A1 (fr) 1997-01-09
KR19990028359A (ko) 1999-04-15
DK0838474T3 (da) 2005-08-01

Similar Documents

Publication Publication Date Title
FI973452L (sv) Strimmig doseringsform för aktivt agens med fördröjd avgivning
FI973828A0 (sv) Föreningar och sammansättningar för tillförsel av aktiva ämnen
DE19681287T1 (de) Orale Formulierung von 2-Methylthienobenzodiazepin
BR1100329A (pt) Composto e formulação farmacêutica
EE9800116A (et) Farmatseutiliselt aktiivsed kinasoliini ühendid
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
FI941787A7 (sv) Elkirurgisk processor och förfarande för att använda densamma
NO944526D0 (no) Medisinsk aerosolformulering
FI956113A0 (sv) Fungicida kombinationer av aktiva ämnen
FI955681A0 (sv) Doseringsform för depressionsmedicin
EE03925B1 (et) Farmakoloogiliselt aktiivse aine valmistamise meetod
BR9610396A (pt) Formulação farmacêutica
DK0805625T3 (da) Insekticidt aktiv sammensætning
FI951306A0 (sv) Ozonvänlig steriliseringsblandning
BR9610821A (pt) Derivado de aminoácido uso de um composto e medicamento contendo o mesmo
NO973471D0 (no) Transdermal formulering
ATA181095A (de) Probiotisch wirksame formulierung
NO943834L (no) Fremgangsmåte ved innkapsling av en aktiv bestanddel
BR9607722A (pt) Formulação transdérmica
FI944974A0 (sv) Kolloidalt dispergerbara formuleringar av verkande ämne
FI952176L (sv) Neutralisering av såpa
ATE228575T1 (de) Wirkstoffkombinationen
FI974601L (sv) Peptid som inhiberar en förhöjning av friglyceridnivån i blodet och inhibitor för förhöjning av triglyceridnivån i blodet, vilken innehåller nämnda peptid som aktiv ingrediens
FI972510A7 (sv) Tiazolidinonföreningar och preparat som innehåller dessa som aktivt ämne för behandling och förebyggande av angina pectoris

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116660

Country of ref document: FI